Menno V Huisman Selected Research

fibrin fragment D (D-dimer)

1/2023	Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis.
1/2022	Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis.
1/2021	Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
1/2021	[Diagnosis of recurrent venous thromboembolism].
1/2020	Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosis.
10/2019	Validation and impact of a simplified clinical decision rule for diagnosing pulmonary embolism in primary care: design of the PECAN prospective diagnostic cohort management study.
1/2019	Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.
1/2019	Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'.
11/2018	Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.
7/2018	Clinical effects of antiplatelet drugs and statins on D-dimer levels.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Menno V Huisman Research Topics

Disease

90	Hemorrhage 03/2024 - 01/2000
66	Pulmonary Embolism 11/2023 - 02/2002
58	Venous Thromboembolism 03/2024 - 01/2000
49	Atrial Fibrillation 01/2024 - 06/2010
36	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 08/2002
35	Stroke (Strokes) 01/2024 - 01/2001
26	Neoplasms (Cancer) 01/2024 - 02/2004
21	Thrombosis (Thrombus) 03/2024 - 12/2002
9	Pulmonary Hypertension 09/2022 - 04/2012
8	Myocardial Infarction 01/2024 - 01/2018
8	Thromboembolism 10/2023 - 06/2010
8	Type 2 Diabetes Mellitus (MODY) 04/2015 - 07/2002
7	Embolism (Embolus) 01/2024 - 02/2002
6	Ischemic Stroke 02/2023 - 04/2016
6	Chronic Renal Insufficiency 12/2022 - 01/2014
6	Heart Failure 01/2022 - 01/2018
6	Wounds and Injuries (Trauma) 07/2021 - 04/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2002
5	COVID-19 01/2024 - 01/2021
4	Subacute Sclerosing Panencephalitis (SSPE) 11/2020 - 08/2013
3	Frailty 04/2024 - 12/2019
3	Obesity 01/2021 - 03/2017
3	Body Weight (Weight, Body) 01/2020 - 10/2003
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 08/2016
2	Dyspnea (Shortness of Breath) 11/2023 - 09/2022
2	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2011
2	Postthrombotic Syndrome 12/2021 - 12/2021
2	Disease Progression 01/2020 - 05/2013
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 01/2017
2	Renal Insufficiency (Renal Failure) 01/2020 - 05/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 05/2014
2	Atherosclerosis 01/2020 - 07/2002
2	Transient Ischemic Attack 06/2018 - 01/2018
2	Hypertension (High Blood Pressure) 01/2018 - 12/2009
2	Vascular Diseases (Vascular Disease) 01/2018 - 11/2013
2	Dyslipidemias (Dyslipidemia) 03/2008 - 07/2002
2	Infections 01/2008 - 04/2005
1	Human Influenza (Influenza) 01/2024

Drug/Important Bio-Agent (IBA)

97	AnticoagulantsIBA 03/2024 - 02/2002
38	Vitamin K FDA Link 01/2024 - 07/2007
34	fibrin fragment D (D-dimer)IBA 01/2023 - 02/2002
31	Dabigatran FDA Link 01/2024 - 06/2010
17	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2024 - 01/2001
16	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2022 - 09/2011
15	RivaroxabanIBA 05/2022 - 11/2006
13	apixabanIBA 01/2024 - 07/2011
10	Enoxaparin (Lovenox)FDA LinkGeneric 05/2018 - 02/2005
9	Factor Xa InhibitorsIBA 01/2024 - 01/2007
8	N(4)-oleylcytosine arabinosideIBA 08/2023 - 02/2017
8	Heparin (Liquaemin)FDA LinkGeneric 09/2021 - 01/2000
8	idarucizumabIBA 03/2019 - 07/2015
6	Dalteparin (Dalteparin Sodium)FDA Link 01/2024 - 09/2018
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2018 - 01/2001
5	cupric sulfide (CuS)IBA 11/2023 - 07/2014
5	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 08/2008
5	Prothrombin (Factor II)IBA 10/2021 - 02/2004
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2021 - 01/2001
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2020 - 01/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2018 - 12/2004
4	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 06/2008
4	edoxabanIBA 12/2021 - 01/2019
4	Thrombin FDA Link 12/2017 - 02/2005
4	Biomarkers (Surrogate Marker)IBA 05/2014 - 07/2002
4	Warfarin (Coumadin)FDA LinkGeneric 06/2010 - 11/2003
3	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2023
3	Indicators and Reagents (Reagents)IBA 08/2023 - 11/2013
3	TroponinIBA 01/2022 - 06/2008
3	Hemostatics (Antihemorrhagics)IBA 10/2021 - 03/2008
3	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2020 - 05/2014
3	Atorvastatin (Lipitor)FDA Link 04/2015 - 07/2002
2	CreatinineIBA 12/2022 - 01/2020
2	PRT064445IBA 10/2021 - 05/2021
2	Hormones (Hormone)IBA 05/2019 - 11/2004
2	C-Reactive ProteinIBA 01/2019 - 05/2008
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2015 - 04/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2015 - 07/2005
2	Contrast MediaIBA 05/2014 - 05/2013
1	ArginaseIBA 01/2024
1	ProteomeIBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Urea (Carbamide)FDA LinkGeneric 01/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2024
1	coumarinIBA 01/2024
1	Propafenone (Rythmol)FDA LinkGeneric 12/2023
1	Verapamil (Calan)FDA LinkGeneric 12/2023

Therapy/Procedure

50	Therapeutics 03/2024 - 11/2004
5	Catheters 01/2023 - 04/2005
4	Drug Therapy (Chemotherapy) 12/2021 - 11/2003
4	Aftercare (After-Treatment) 12/2018 - 08/2002
4	Central Venous Catheters 01/2008 - 11/2003
3	Secondary Prevention 12/2021 - 08/2005
3	Anticoagulation Reversal 05/2017 - 11/2016
3	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2008 - 11/2006
2	Heart-Assist Devices 01/2022 - 06/2020
2	Duration of Therapy 03/2017 - 01/2017
2	Cardiopulmonary Resuscitation (CPR) 10/2016 - 02/2015
2	Contraindications 04/2012 - 09/2011
2	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2011 - 11/2010
1	Polypharmacy 04/2024